MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

20 May 2024 Evaluate
The sales is pegged at Rs. 115.50 millions for the March 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 144.00 millions during the year-ago period.The Company to register a -65.80%  fall in the net profit for the quarter ended March 2024.Operating profit for the quarter ended March 2024 decreased to 53.38 millions as compared to 71.26 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 115.50 144.00 -19.79 448.81 516.22 -13.06 448.81 516.22 -13.06
Other Income 0.09 0.20 -55.00 0.39 0.36 8.33 0.39 0.36 8.33
PBIDT 53.38 71.26 -25.09 211.23 215.23 -1.86 211.23 215.23 -1.86
Interest 15.18 20.14 -24.63 77.78 76.51 1.66 77.78 76.51 1.66
PBDT 38.20 51.12 -25.27 133.45 138.72 -3.80 133.45 138.72 -3.80
Depreciation 24.26 22.60 7.35 92.91 92.66 0.27 92.91 92.66 0.27
PBT 13.94 28.52 -51.12 40.54 46.06 -11.98 40.54 46.06 -11.98
TAX 6.97 8.14 -14.37 15.33 19.72 -22.26 15.33 19.72 -22.26
Deferred Tax -0.32 0.78 -141.03 -1.43 9.41 -115.20 -1.43 9.41 -115.20
PAT 6.97 20.38 -65.80 25.21 26.34 -4.29 25.21 26.34 -4.29
Equity 149.04 149.04 0.00 149.04 149.04 0.00 149.04 149.04 0.00
PBIDTM(%) 46.22 49.49 -6.61 47.06 41.69 12.88 47.06 41.69 12.88
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..